Jonathan Feelemyer, PhD, MS, MPhil
NYU School of Global Public Health - Project Director
Email: jf3880@nyu.edu
Education
PhD, Epidemiology, NYU Grossman School of MedicineMPhil, Epidemiology, NYU Grossman School of Medicine
MS, Epidemiology, University at Albany School of Public Health
BA, Health and Society, University of Rochester
Research Interests
Injecting drug use, epidemiology, HIV, HCV, sexually transmitted diseases, harm reduction, research synthesis BIO
Jonathan Feelemyer is a project director at the NYU School of Global Public Health. His research interests include HIV, hepatitis C, sexually transmitted diseases, injection drug use, and harm reduction for at risk populations. His research is focused on international settings specifically in Southeast Asia and Eastern Europe. He has published numerous publications in academic journals and has presented his work at national and international conferences. He has collaborated with researchers from New York University, Columbia University, the Centers for Disease Control and Prevention, and researchers in Estonia, Vietnam, Russia, France, and other countries. He has worked collaboratively on numerous meta-analysis and systematic review studies, synthesizing research from multiple countries and time periods examining different research topics related to HIV and HCV. He currently works with Dr. Don Des Jarlais on research projects addressing harm reduction, combined prevention, and reductions in HIV and HCV among different at risk populations, with special focus on high prevalence settings worldwide. Projects
Principal Investigator, Comparison of Stigmatization of Monkeypox, Injecting Drug Use, HIV/AIDS, and COVID-19. Completed
Publications
Recent
Des Jarlais DC, Weng CA, Feelemyer J, McKnight C (2023).
Non-fatal drug overdose among persons who inject drugs during first two years of the COVID-19 pandemic in New York City: Prevalence, risk factors
Drug and Alcohol Dependence Reports, 8, 100171. doi: 10.1016/j.dadr.2023.100171. PMCID: PMC10247299.
Non-fatal drug overdose among persons who inject drugs during first two years of the COVID-19 pandemic in New York City: Prevalence, risk factors
Drug and Alcohol Dependence Reports, 8, 100171. doi: 10.1016/j.dadr.2023.100171. PMCID: PMC10247299.
Feelemyer JP, Richard E, Khan MR, Scheidell JD, Caniglia EC, Manandhar-Sasaki P, Ban KF, Charles D, Braithwaite RS (2023).
Does the association between stimulant use and high risk sexual behavior vary by injection drug use, sexual minority status, or HIV infection status? A meta-analysis
AIDS and Behavior, 27 (9), 2883-2890. doi: 10.1007/s10461-023-04012-4. PMCID: PMC10423740.
Does the association between stimulant use and high risk sexual behavior vary by injection drug use, sexual minority status, or HIV infection status? A meta-analysis
AIDS and Behavior, 27 (9), 2883-2890. doi: 10.1007/s10461-023-04012-4. PMCID: PMC10423740.
Feelemyer JP, Duncan DT, Remch M, Kaufman JS, Cleland CM, Geller AB, Dyer TV, Scheidell JD, Turpin RE, Brewer RA, Hucks-Ortiz C, Mazumdar M, Mayer KH, Khan MR (2023).
Associations between police harassment and distrust in and reduced access to healthcare among Black sexual minority men: A longitudinal analysis of HPTN 061
PLoS One, 18 (8), e0290378. doi: 10.1371/journal.pone.0290378. PMCID: PMC10437825.
Associations between police harassment and distrust in and reduced access to healthcare among Black sexual minority men: A longitudinal analysis of HPTN 061
PLoS One, 18 (8), e0290378. doi: 10.1371/journal.pone.0290378. PMCID: PMC10437825.
Remch M, Scheidell JD, Cleland CM, Turpin R, Duncan DT, Dyer TT, Kaufman JS, Mazumdar M, Brewer R, Feelemyer J, Mayer KH, Khan MR (2023).
Mediation of the effect of incarceration on selling sex among Black sexual minority men and Black transgender women in the HPTN 061 study
AIDS and Behavior, 27 (8), 2791-2802. doi: 10.1007/s10461-023-04003-5.
Mediation of the effect of incarceration on selling sex among Black sexual minority men and Black transgender women in the HPTN 061 study
AIDS and Behavior, 27 (8), 2791-2802. doi: 10.1007/s10461-023-04003-5.
Uuskula A, Feelemyer J, Des Jarlais DC (2023).
HIV treatment, antiretroviral adherence and AIDS mortality in people who inject drugs: A scoping review
European Journal of Public Health, 33 (3), 381-388. doi: 10.1093/eurpub/ckad008. PMCID: PMC10234656.
HIV treatment, antiretroviral adherence and AIDS mortality in people who inject drugs: A scoping review
European Journal of Public Health, 33 (3), 381-388. doi: 10.1093/eurpub/ckad008. PMCID: PMC10234656.
Notable
Retention of participants in medication-assisted programs in low- and middle-income countries: An international systematic review
Addiction, 109 (1), 20-32. doi: 10.1111/add.12303. PMCID: PMC5312702.
Feelemyer J, Des Jarlais DC, Arasteh K, Phillips BW, Hagan H (2014).
Changes in quality of life (WHOQOL-BREF) and addiction severity index (ASI) among participants in opioid substitution treatment (OST) in low and middle income countries: An international systematic review
Drug and Alcohol Dependence, 134, 251-258. doi: 10.1016/j.drugalcdep.2013.10.011. PMCID: PMC3880839.
Feelemyer J, Des Jarlais D, Arasteh K, Uuskula A (2015).
Adherence to antiretroviral medications among persons who inject drugs in transitional, low and middle income countries: An international systematic review
AIDS and Behavior, 19 (4), 575-583. doi: 10.1007/s10461-014-0928-3. PMCID: PMC4393761.
Jonathan Feelemyer's ResearchGate Profile